Clinical trial

A Prospective Phase II Dose Escalation Study Using IMRT for High Risk N0 M0 Prostate Cancer. ICORG 08-17

NCT00951535

StatusACTIVE_NOT_RECRUITING

Study typeINTERVENTIONAL

Start date2009-07-20

PhasePHASE2

Study timeline

Study start (actual)2009-07-20Date precision: day

Registry last updated2026-04-17

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Prostate Cancerunresolved

Interventions

questionnaire administrationOTHER

quality-of-life assessmentPROCEDURE

image-guided radiation therapyRADIATION

intensity-modulated radiation therapyRADIATION

radiation therapy treatment planning/simulationRADIATION

Sponsors & collaborators

Cancer Trials Irelandlead sponsor

Mapped research locations

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00951535 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.